Novabay Pharmaceuticals Inc Ret. on assets
What is the Ret. on assets of Novabay Pharmaceuticals Inc?
The Ret. on assets of Novabay Pharmaceuticals Inc is -136.86%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NYSEMKT compared to Novabay Pharmaceuticals Inc
What does Novabay Pharmaceuticals Inc do?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Companies with ret. on assets similar to Novabay Pharmaceuticals Inc
- China International Investments has Ret. on assets of -137.76%
- Libero Copper & Gold has Ret. on assets of -137.48%
- SenesTech Inc has Ret. on assets of -137.32%
- Eyenovia Inc has Ret. on assets of -137.04%
- Monarca Minerals has Ret. on assets of -137.01%
- Venture Minerals has Ret. on assets of -136.89%
- Novabay Pharmaceuticals Inc has Ret. on assets of -136.86%
- Cabral Gold has Ret. on assets of -136.71%
- Technical Communications has Ret. on assets of -136.68%
- Forward Water Technologies has Ret. on assets of -136.61%
- Minerva Intelligence has Ret. on assets of -136.32%
- 102570 has Ret. on assets of -136.31%
- Next Dynamics Inc has Ret. on assets of -135.98%